Phosphoregulated FMRP phase separation models activity-dependent translation through bidirectional control of mRNA granule formation B Tsang, J Arsenault, RM Vernon, H Lin, N Sonenberg, LY Wang, A Bah, ... Proceedings of the National Academy of Sciences 116 (10), 4218-4227, 2019 | 274 | 2019 |
Reduced phenotypic severity following adeno-associated virus-mediated Fmr1 gene delivery in fragile X mice S Gholizadeh, J Arsenault, ICY Xuan, LK Pacey, DR Hampson Neuropsychopharmacology 39 (13), 3100-3111, 2014 | 90 | 2014 |
Mammalian susceptibility to a neonicotinoid insecticide after fetal and early postnatal exposure AP Burke, Y Niibori, H Terayama, M Ito, C Pidgeon, J Arsenault, ... Scientific Reports 8 (1), 16639, 2018 | 75 | 2018 |
Identification of a molecular locus for normalizing dysregulated GABA release from interneurons in the Fragile X brain YM Yang, J Arsenault, A Bah, M Krzeminski, A Fekete, OY Chao, ... Molecular psychiatry 25 (9), 2017-2035, 2020 | 66 | 2020 |
FMRP expression levels in mouse central nervous system neurons determine behavioral phenotype J Arsenault, S Gholizadeh, Y Niibori, LK Pacey, SK Halder, E Koxhioni, ... Human gene therapy 27 (12), 982-996, 2016 | 64 | 2016 |
Synthetic self-assembling clostridial chimera for modulation of sensory functions E Ferrari, C Gu, D Niranjan, L Restani, C Rasetti-Escargueil, I Obara, ... Bioconjugate chemistry 24 (10), 1750-1759, 2013 | 45 | 2013 |
Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice M Maiarù, C Leese, M Certo, I Echeverria-Altuna, AS Mangione, ... Science Translational Medicine 10 (450), eaar7384, 2018 | 41 | 2018 |
Stapling of the botulinum type A protease to growth factors and neuropeptides allows selective targeting of neuroendocrine cells J Arsenault, E Ferrari, D Niranjan, SAG Cuijpers, C Gu, Y Vallis, J O'Brien, ... Journal of neurochemistry 126 (2), 223-233, 2013 | 38 | 2013 |
A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity J Arsenault, J Lehoux, L Lanthier, J Cabana, G Guillemette, P Lavigne, ... Pharmacogenetics and genomics 20 (6), 377-388, 2010 | 31 | 2010 |
Assembly of protein building blocks using a short synthetic peptide E Ferrari, M Soloviev, D Niranjan, J Arsenault, C Gu, Y Vallis, J O’Brien, ... Bioconjugate chemistry 23 (3), 479-484, 2012 | 27 | 2012 |
Botulinum protease‐cleaved SNARE fragments induce cytotoxicity in neuroblastoma cells J Arsenault, SAG Cuijpers, E Ferrari, D Niranjan, A Rust, C Leese, ... Journal of Neurochemistry 129 (5), 781-791, 2014 | 22 | 2014 |
Optimized heterologous transfection of viable adult organotypic brain slices using an enhanced gene gun J Arsenault, JA O’Brien BMC Research Notes 6, 1-9, 2013 | 19 | 2013 |
Preliminary biochemical characterization of the novel, non-AT1, non-AT2 angiotensin binding site from the rat brain VT Karamyan, J Arsenault, E Escher, RC Speth Endocrine 37, 442-448, 2010 | 17 | 2010 |
Temperature dependent photolabeling of the human angiotensin II type 1 receptor reveals insights into its conformational landscape and its activation mechanism J Arsenault, J Cabana, D Fillion, R Leduc, G Guillemette, P Lavigne, ... Biochemical pharmacology 80 (7), 990-999, 2010 | 15 | 2010 |
Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex J Arsenault, AWM Hooper, S Gholizadeh, T Kong, LK Pacey, E Koxhioni, ... Human molecular genetics 29 (23), 3744-3756, 2020 | 12 | 2020 |
Regioselective biolistic targeting in organotypic brain slices using a modified gene gun J Arsenault, A Nagy, JT Henderson, JA O'Brien JoVE (Journal of Visualized Experiments), e52148, 2014 | 10 | 2014 |
Temperature‐dependent variations of ligand‐receptor contact points in hAT1 J Arsenault, MPLH Renaud, M Clement, D Fillion, G Guillemette, R Leduc, ... Journal of Peptide Science: An Official Publication of the European Peptide …, 2007 | 8 | 2007 |
Mammalian susceptibility to a neonicotinoid insecticide after fetal and early postnatal exposure. Sci Rep 8: 16639 AP Burke, Y Niibori, H Terayama, M Ito, C Pidgeon, J Arsenault, ... | 6 | 2018 |
Purification and partial characterization of a novel, non‐AT1, non‐AT2 binding site for angiotensins in the rat brain VT Karamyan, J Arsenault, K Klarskov, Z Shariat‐Madar, E Escher, ... The FASEB Journal 23, 943.8-943.8, 2009 | 4 | 2009 |
Temperature-induced Ligand Contact Point Variations of the hAT1 Receptor and of the Constitutively Active Mutant N111G-hAT1 J Arsenault, MPLH Renaud, M Clément, D Fillion, G Guillemette, R Leduc, ... Peptides for Youth: The Proceedings of the 20th American Peptide Symposium …, 2009 | 2 | 2009 |